About SHS
SHS is a private equity firm founded in 1993. It is primarily based in Tubingen, Germany. As of Oct 2026, SHS has a portfolio of 45 companies, comprising 45 funding rounds and 11 acquisitions. The firm primarily invests in companies based in Germany and Switzerland. Its portfolio is spread across a wide range of sectors from Life Sciences to High Tech. Most recently it acquired stakes in Ackermann Surgical on Jul 08, 2025.
Overall SHS portfolio has seen 2 IPOs and 15 acquisitions, namely PathoQuest, Affimed Therapeutics and ProBioGen AG. A lot of funds co-invest with SHS, with names like Kfw sharing a substantial percentage of its portfolio.
SHS has a team of 20 people, including 7 partners.
Key Metrics
Founded Year
1993
Location
Tubingen, Germany
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
SHS's Portfolio
SHS has a portfolio of 45 companies. They have invested in a total of 45 companies. Their most recent investment was in Salvia BioElectronics (Series B round) on May 27, 2025. Here are the most recent investments by SHS:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
May 27, 2025 | Series B | 2300 | ||
Jan 15, 2025 | PE | 2717 | ||
Oct 07, 2024 | Series A | 3298 | - | |
Aug 2023 | Seed | 1594 | - |
_1559282484523.png?devicePixelRatio=2&height=20&width=20){kind=logo}
SHS has acquired 11 companies. Their most recent acquisition was of Ackermann Surgical on Jul 08, 2025. Here are the most recent acquisitions by SHS:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jul 08, 2025 | Manufacturer of precision-made surgical instruments and systems. It produces a range of products for various surgical specialties, including laparoscopy, arthroscopy, and thoracic surgery. The company also offers fluid management systems and specialized instruments for ENT, trauma, neuro, and plastic surgery. A focus on meticulous craftsmanship and adherence to stringent regulatory standards is evident in its product offerings. After-sales service includes product training, maintenance, and repair. The company also engages in medical device research and development. | - | - | |
Nov 26, 2024 | Provider of home medical devices for electrotherapy, movement, and compression therapy | - | - | |
Jul 07, 2023 | A contract manufacturer of orthobiologic calcium compositions for the orthopedic industry | - | 2008 | |
Feb 03, 2022 | Manufacturer of temperature controlled storage units | - | 2012 |
Here is the portfolio snapshot of SHS:
Investments by Year
The maximum number of investments were made in 2020
Acquisitions by Year
The maximum number of acquisitions were made in 2025
Portfolio by Location
Companies are primarily in Germany and Switzerland
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of SHS
SHS has a team of 20 members including 7 Partners located in Germany, Austria and 2 more locations. SHS's team sits on the board of 1 company.Here is a list of top team members in SHS:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Stuttgart | - | ||
Partner | Germany | - | ||
Partner | Stuttgart | - | ||
Partner | Stuttgart | - | ||
Partner | Tubingen | - | ||
Partner | Munich | - | ||
Partner | - | - | ||
Advisor | Switzerland | - | ||
Advisor | Austria | - | ||
Advisor | Frankfurt | - | ||
Advisor | Maastricht | - |
Co-investors of SHS
Over the past 33 years, 24 investors have co-invested in SHS's portfolio companies.
- Top Co-investors of SHS: 24 investors entered a company along with SHS. These include investors like Kfw (6 companies).
SHS News
•
SHS Capital Acquires Majority Stake in Dutch Pharmaceutical CDMO Basic PharmaWebDisclosure•Jul 14, 2026•SHS
•
•
SHS Capital Sells PathoQuest to Charles River LaboratoriesWebDisclosure•Jan 13, 2026•PathoQuest, SHS
•
•
SHS Capital Invests in German Endoscopy Group Through SHS VI FundWebDisclosure•Dec 17, 2025•SHS, EMOS Technology
•
SHS Capital acquires majority of Ackermann Instruments, aims to build leading medtech groupFinanzNachrichten•Jul 08, 2025•SHS, Ackermann Surgical
•
Salvia BioElectronics Secures $60M to Develop Migraine ImplantTech Funding News•May 27, 2025•Salvia BioElectronics, Innovation Industries, Invest-NL, European Innovation Council and 4 others
•
Görg advises SHS Capital for acquisition financing for acquisition of medical technology Rostock GmbHRecht & Politik•Dec 10, 2024•SHS, Mtronline
•
RSM Ebner Stolz advises SHS Capital on the acquisition of a majority stake in Medizintechnik Rostock GmbHmajunke.com•Dec 02, 2024•SHS, Ebner Stolz
•
